The Valley Desk

NCT06508320 · Interventional trial

A Clinical Study to Investigate the Safety and Immunogenicity in Relation to Product Attributes of mRNA-1083 (Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2] and Influenza Vaccine)

Overall registry status Completed

Phase 2

Conditions Influenza, SARS-CoV-2

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov